COVID-19 and Alzheimer’s disease in the ADNI cohort

Read the full article

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

INTRODUCTION: There is growing evidence that COVID-19 infection in older adults increases the risk of diagnosis of Alzheimer’s disease and accelerates cognitive decline. We hypothesized that participants reporting COVID-19 infection would have greater cognitive and functional decline and greater occurrence of neuropsychiatric symptoms after COVID-19 infection in comparison to uninfected matched controls. METHODS This secondary data analysis from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort examined participants with and without self-reported history of COVID-19 infection comparing visits before and after infection. RESULTS The 16 participants included in the COVID-19 cohort and the 32 controls, had similar changes in cognitive, functionality and behavioral measures between study visits. CONCLUSIONS While there is evidence that COVID-19 infection increases the risk for depression, cognitive changes and conversion to dementia, this examination of a well characterized cohort of at risk and cognitive impaired individuals did not find evidence for the impact of COVID-19 after infection.

Article activity feed